Your browser doesn't support javascript.
Altered Surface Expression of Insulin-Degrading Enzyme on Monocytes and Lymphocytes from COVID-19 Patients Both at Diagnosis and after Hospital Discharge.
González-Casimiro, Carlos M; Arribas-Rodríguez, Elisa; Fiz-López, Aida; Casas, Javier; Gutiérrez, Sara; Tellería, Pablo; Novoa, Cristina; Rojo-Rello, Silvia; Tamayo, Eduardo; Orduña, Antonio; Dueñas, Carlos; Bernardo, David; Perdomo, German.
  • González-Casimiro CM; Physiopathology of Metabolic Diseases Lab, Unidad de Excelencia Instituto de Biología y Genética Molecular (IBGM), Consejo Superior de Investigaciones Científicas (CSIC)-Universidad de Valladolid, 47003 Valladolid (UVa), Spain.
  • Arribas-Rodríguez E; Mucosal Immunology Lab, Unidad de Excelencia Instituto de Biología y Genética Molecular (IBGM), Consejo Superior de Investigaciones Científicas (CSIC)-Universidad de Valladolid (UVa), 47003 Valladolid, Spain.
  • Fiz-López A; Mucosal Immunology Lab, Unidad de Excelencia Instituto de Biología y Genética Molecular (IBGM), Consejo Superior de Investigaciones Científicas (CSIC)-Universidad de Valladolid (UVa), 47003 Valladolid, Spain.
  • Casas J; Microscopy Unit, Unidad de Excelencia Instituto de Biología y Genética Molecular (IBGM), Consejo Superior de Investigaciones Científicas (CSIC)-Universidad de Valladolid (UVa), 47003 Valladolid, Spain.
  • Gutiérrez S; Internal Medicine Department, Hospital Clínico Universitario de Valladolid, 47003 Valladolid, Spain.
  • Tellería P; Internal Medicine Department, Hospital Clínico Universitario de Valladolid, 47003 Valladolid, Spain.
  • Novoa C; Internal Medicine Department, Hospital Clínico Universitario de Valladolid, 47003 Valladolid, Spain.
  • Rojo-Rello S; Microbiology and Immunology Unit, Hospital Clínico Universitario de Valladolid, 47003 Valladolid, Spain.
  • Tamayo E; Department of Surgery, University of Valladolid, 47002 Valladolid, Spain.
  • Orduña A; Department of Anaesthesiology and Critical Care, Hospital Clínico Universitario de Valladolid, 47003 Valladolid, Spain.
  • Dueñas C; Centro de Investigación Biomédica en Red de Enfermedades Infecciosas (CIBERINFEC), Instituto de Salud Carlos III, 28029 Madrid, Spain.
  • Bernardo D; BioCritic, Group for Biomedical Research in Critical Care Medicine, 47005 Valladolid, Spain.
  • Perdomo G; Microbiology and Immunology Unit, Hospital Clínico Universitario de Valladolid, 47003 Valladolid, Spain.
Int J Mol Sci ; 23(19)2022 Sep 21.
Article in English | MEDLINE | ID: covidwho-2043770
ABSTRACT
Although the COVID-19 disease has developed into a worldwide pandemic, its pathophysiology remains to be fully understood. Insulin-degrading enzyme (IDE), a zinc-metalloprotease with a high affinity for insulin, has been found in the interactomes of multiple SARS-CoV-2 proteins. However, the relevance of IDE in the innate and adaptative immune responses elicited by circulating peripheral blood mononuclear cells is unknown. Here, we show that IDE is highly expressed on the surface of circulating monocytes, T-cells (both CD4+ and CD4-), and, to a lower extent, in B-cells from healthy controls. Notably, IDE's surface expression was upregulated on monocytes from COVID-19 patients at diagnosis, and it was increased in more severe patients. However, IDE's surface expression was downregulated (relative to healthy controls) 3 months after hospital discharge in all the studied immune subsets, with this effect being more pronounced in males than in females, and thus it was sex-dependent. Additionally, IDE levels in monocytes, CD4+ T-cells, and CD4- T-cells were inversely correlated with circulating insulin levels in COVID-19 patients (both at diagnosis and after hospital discharge). Of note, high glucose and insulin levels downregulated IDE surface expression by ~30% in the monocytes isolated from healthy donors, without affecting its expression in CD4+ T-cells and CD4- T-cells. In conclusion, our studies reveal the sex- and metabolism-dependent regulation of IDE in monocytes, suggesting that its regulation might be important for the recruitment of immune cells to the site of infection, as well as for glucometabolic control, in COVID-19 patients.
Subject(s)
Keywords

Full text: Available Collection: International databases Database: MEDLINE Main subject: COVID-19 / Insulysin Type of study: Diagnostic study Limits: Female / Humans / Male Language: English Year: 2022 Document Type: Article Affiliation country: Ijms231911070

Similar

MEDLINE

...
LILACS

LIS


Full text: Available Collection: International databases Database: MEDLINE Main subject: COVID-19 / Insulysin Type of study: Diagnostic study Limits: Female / Humans / Male Language: English Year: 2022 Document Type: Article Affiliation country: Ijms231911070